Skip to main content
 

Microbiome research at the NIH: From disease to therapeutics

Wednesday, October 10, 2012 — Concurrent Symposia Session III

2:00 p.m. – 4:00 p.m.

Balcony C

Co-chairs

  • Rashmi Sinha, NCI
  • Leigh Greathouse, NCI

Program

Symposium on Microbiome Research at the NIH: From disease to therapeutics. This symposium will center on current work within the NIH intramural program, and will focus on characterization of the microbiome, etiologic investigations, and the possible use of microorganisms in therapy. The symposium will end with a discussion including the speakers, selected poster presenters, and a panel of experts, which will be lead by the session chairs. The purpose of this discussion will be to address the research needed to advance interdisciplinary work on the microbiome at the NIH so that both basic science and epidemiology are fully integrated.

Compartmentalized control of skin immunity by resident commensals
Shruti Naik, NIAID

Upper GI microbiome and mortality
Christian Abnet, NCI

Lactobacillus-mediated priming of the respiratory mucosa protects against lethal virus infection
Katia Garcia-Crespo, NIAID

Live biotherapeutic approaches to HIV prevention
Laurel Lagenaur, NCI

Gut commensal bacteria promote anti-tumor innate immune responses in distant tumors after immunotherapy and chemotherapy FARE Award Winner
Noriho Iida, NCI

1.Roberto Flores (NCI) Standardization of specimen collection and handling procedures for gut microbiome analyses 2.John Grainger (NIAID) Inflammatory macrophages regulate pathologic responses to commensals during acute gastrointestinal infection 3.Reiko Horai (NEI) Commensal microbiota as a trigger for ‘Spontaneous’ Autoimmune Uveitis
Poster Blitz, NCI

back to top